glp-1 cardiovascular outcomes trial results august 2025 Comparative effectiveness of receptor agonists on among adults with type 2 diabetes and moderate cardiovascular risk: emulation of a target ISPOR 2025: Exploring reasons for

glp-1 cardiovascular outcomes trial results august 2025

glp-1 cardiovascular outcomes trial results august 2025 Comparative effectiveness of receptor agonists on among adults with type 2 diabetes and moderate cardiovascular risk: emulation of a target ISPOR 2025: Exploring reasons for

Name: glp-1 cardiovascular outcomes trial results august 2025 Comparative effectiveness of receptor agonists on among adults with type 2 diabetes and moderate cardiovascular risk: emulation of a target ISPOR 2025: Exploring reasons for
Brand: wefit.es
SKU: 89402096863
Price: 28.20 USD
Availability: InStock
Rating: 4.5391 (11 reviews)

SKU: 89402096863

4.5

EUR28.20 EUR67.20

Pay in 4 interest-free payments of $7.05 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 13 - Aug 18

Description

Vontas JG, Small GJ, Hemingway J

Nature 445 : 643647

Rather than working with multiple separate compounds, researchers can evaluate a single, consistent formulation, helping improve efficiency and reduce variability during experimental setup